Evidence map›Paper›PMID 36430759›Full record

ArticleInternational journal of molecular sciences2022

The Role of TKS5 in Chromosome Stability and Bladder Cancer Progression.

Wenya Wang, Xi Zheng, Anca Azoitei, Axel John, Friedemann Zengerling, Felix Wezel, Christian Bolenz, Cagatay Günes

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Dna aneuploidy and urothelial carcinoma: A meta-analysis.Current therapeutic research, clinical and experimental · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Wenya WangDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.ORCID 0000-0001-6891-8588
Xi ZhengDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Anca AzoiteiDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Axel JohnDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Friedemann ZengerlingDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Felix WezelDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.ORCID 0000-0003-0675-181X
Christian BolenzDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.
Cagatay GünesDepartment of Urology, Ulm University Hospital, 89081 Ulm, Germany.ORCID 0000-0003-4301-2223
University Hospital Ulm · DE

Funding

Wilhelm Sander Stiftung 2019.038.1
6 · The paper itself

Abstract

TKS5 promotes invasion and migration through the formation of invadopodia in some tumour cells, and it also has an important physiological function in cell migration through podosome formation in various nontumour cells. To date, the role of TKS5 in urothelial cells, and its potential role in BC initiation and progression, has not yet been addressed. Moreover, the contribution of TKS5 to ploidy control and chromosome stability has not been reported in previous studies. Therefore, in the present study, we wished to address the following questions: (i) Is TKS5 involved in the ploidy control of urothelial cells? (ii) What is the mechanism that leads to aneuploidy in response to TKS5 knockdown? (iii) Is TKS5 an oncogene or tumour-suppressor gene in the context of BC? (iv) Does TKS5 affect the proliferation, migration and invasion of BC cells? We assessed the gene and protein expressions via qPCR and Western blot analyses in a set of nontumour cell strains (Y235T, HBLAK and UROtsa) and a set of BC cell lines (RT4, T24, UMUC3 and J82). Following the shRNA knockdown in the TKS5-proficient cells and the ectopic TKS5 expression in the cell lines with low/absent TKS5 expression, we performed functional experiments, such as metaphase, invadopodia and gelatine degradation assays. Moreover, we determined the invasion and migration abilities of these genetically modified cells by using the Boyden chamber and wound-healing assays. The TKS5 expression was lower in the bladder cancer cell lines with higher invasive capacities (T24, UMUC3 and J82) compared to the nontumour cell lines from human ureter (Y235T, HBLAK and UROtsa) and the noninvasive BC cell line RT4. The reduced TKS5 expression in the Y235T cells resulted in augmented aneuploidy and impaired cell division. According to the Boyden chamber and wound-healing assays, TKS5 promotes the invasion and migration of bladder cancer cells. According to the present study, TKS5 regulates the migration and invasion processes of bladder cancer (BC) cell lines and plays an important role in genome stability.

Indexed as

Urinary Bladder NeoplasmsAdaptor Proteins, Vesicular TransportAneuploidyChromosomal InstabilityHumansUrinary BladderAdaptor Proteins, Vesicular Transportaneuploidybladder cancerchromosome instabilityinvadopodiaTKS5

Identifiers

PMID36430759
PMCPMC9698602
OpenAlexW4309461902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.